CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
tDCSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04799405
NCT04799405N/ACompleted
CompareCT.gov

Supervised Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorder

Hebrew SeniorLife·interventional·Posted Mar 16, 2021·Updated Mar 24, 2022

In Brief

A clinical study evaluating tDCS for Major Depressive Disorder. Completed, enrolled 5 participants across 1 site.

Detailed Summary

The investigators propose a study of telehealth supervised, caregiver-delivered, home-based transcranial direct current stimulation (tDCS) for antidepressant treatment of patients with an acute depressive episode.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 16, 2021
Enrollment StartSep 24, 2020
Primary CompletionJul 2, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.3 years ago

Interventions

tDCSdevice

Daily sessions (28 daily sessions): The device will be used to apply 30 minutes of tDCS to the participant with MDD's scalp in each of 28 daily sessions. Thereafter, participants with MDD will undergo a taper phase of an additional 9 sessions of tDCS applied in progressively decreasing frequency until day #60 of the study as follows: 1. First taper phase: three 30 minutes tDCS sessions applied every other day; 2. Second taper phase: three 30 minutes tDCS sessions applied one every third day; 3. Third and final taper phase: three final 30 minutes tDCS sessions applied one every fourth day.